EN
Thymosin Alpha-1
10 mg · Vial / Pen
Thymosin Alpha-1 is a distinct research compound. A related naming family does not make it TB-500 or thymosin beta-4.
- Thymosin Alpha-1
- 10 mg per unit
- Vial / Pen
- Batch information as labelled
- Storage according to product label
- Shipping across the EU
COA batch
Vials and pens of the same compound and strength use the same material batch. The report covers the starting material.
Support through delivery
Your satisfaction comes first. If your parcel is lost in transit, we send a replacement free of charge. Our support team also helps personally with damaged or incorrect items. Details & contact
Batch, shipping & returns
Find the batch identification on the product packaging and match it to a relevant published lab report. An analytical result applies only to the sample, batch and test method named in that report.
All pens are sent using cold-chain shipping in insulated packaging with aluminium foil inside and a polystyrene insulation layer. Cold-chain shipping is automatically included with every pen order at no extra charge. The regular shipping cost for your delivery address is shown at checkout. After delivery, follow the storage instructions on the product label.
Vials can be returned with their protective cap unopened and intact. We do not offer voluntary returns for pens because possible tampering after delivery cannot reliably be ruled out. Statutory withdrawal and defect rights remain unaffected. Contact us with your order number and we will explain the appropriate process. Returns & claims.
Pre-filled research format · Cold-chain packaging included. Standard shipping charges apply.
- Product
- Thymosin Alpha-1
- Format
- Vial / Pen
- Total content
- 10 mg
- Composition
- Thymosin Alpha-1
- Storage
- According to label and batch documentation
- Quality documentation
- Only as documented in the relevant published batch report
- Pen volume
- 3 ml
- Clicks per full pen
- 300
- Maximum per dial setting
- 60
- SKU
- thymosin-alpha-1-10mg
Thymosin Alpha-1: Immune-cell models and their limits
Thymosin Alpha-1 is a distinct research compound. A related naming family does not make it TB-500 or thymosin beta-4.
Dendritic cells in the laboratory
A 2007 study examined differentiation and maturation of dendritic cells derived from human CD14-positive monocytes. Measurements included cell characteristics and functional responses in a controlled cell system.
Distinguishing model and organism
An experiment using human cells is not a clinical study in people. An altered cellular response can address a mechanistic question; a health benefit would require separate investigation using suitable clinical outcomes.
The formats offered
Thymosin Alpha-1 is listed as a 10 mg vial and a 10 mg pen. The amount describes total content. For the pre-filled format, volume, solvent and batch documentation must also be considered.
Avoid transferring findings between thymosins
Findings for thymosin alpha-1 cannot be used as evidence for TB-500 simply because the names are similar. The reverse also applies. Identity, sequence and test material need unambiguous identification before comparison.
Read the full research article →
